| Kerri J Kirchhoff, MD | |
|
3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112-4455 | |
| (405) 945-4741 | |
| (888) 972-5320 |
| Full Name | Kerri J Kirchhoff |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 3433 Nw 56th St, Suite C-40, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720081623 | NPI | - | NPPES |
| P00144981 | Other | OK | RAILROAD |
| 100180830B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 18950 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Lakeside Women's Hospital, A Member Of Integris He | Oklahoma city, OK | Hospital |
| Integris Canadian Valley Hospital | Yukon, OK | Hospital |
| Integris Health Edmond | Edmond, OK | Hospital |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Llc | 4082692496 | 19 |
News Archive
A new report combining perspectives from a range of obesity experts identifies genetic, epigenetic and neuro-hormonal differences between individuals as one of the key challenges associated with weight loss and long-term weight control.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
New research findings from a team at the Providence Heart + Lung Institute at St. Paul's Hospital and the University of British Columbia (UBC) may lead to new treatment options for abdominal aortic aneurysms (AAA) - a potentially fatal disease that currently has no pharmacological treatments.
Researchers at Sanford Burnham Prebys Medical Discovery Institute in Lake Nona, Florida have shown that enhanced natriuretic peptide (NP) signaling in adipose tissue protects against obesity and insulin resistance.
› Verified 4 days ago
| Entity Name | Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907916 PECOS PAC ID: 4082692496 Enrollment ID: O20040712001225 |
News Archive
A new report combining perspectives from a range of obesity experts identifies genetic, epigenetic and neuro-hormonal differences between individuals as one of the key challenges associated with weight loss and long-term weight control.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
New research findings from a team at the Providence Heart + Lung Institute at St. Paul's Hospital and the University of British Columbia (UBC) may lead to new treatment options for abdominal aortic aneurysms (AAA) - a potentially fatal disease that currently has no pharmacological treatments.
Researchers at Sanford Burnham Prebys Medical Discovery Institute in Lake Nona, Florida have shown that enhanced natriuretic peptide (NP) signaling in adipose tissue protects against obesity and insulin resistance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kerri J Kirchhoff, MD 3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112-4455 Ph: (405) 945-4741 | Kerri J Kirchhoff, MD 3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112-4455 Ph: (405) 945-4741 |
News Archive
A new report combining perspectives from a range of obesity experts identifies genetic, epigenetic and neuro-hormonal differences between individuals as one of the key challenges associated with weight loss and long-term weight control.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.
New research findings from a team at the Providence Heart + Lung Institute at St. Paul's Hospital and the University of British Columbia (UBC) may lead to new treatment options for abdominal aortic aneurysms (AAA) - a potentially fatal disease that currently has no pharmacological treatments.
Researchers at Sanford Burnham Prebys Medical Discovery Institute in Lake Nona, Florida have shown that enhanced natriuretic peptide (NP) signaling in adipose tissue protects against obesity and insulin resistance.
› Verified 4 days ago
Dr. Jennifer Kathleen Hinkle, MD Radiology Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-2589 | |
Dr. Bryan Lee Vanzandt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4625 S Western Ave, Oklahoma City, OK 73109 Phone: 405-632-2323 Fax: 405-631-9315 | |
Charles Eric Eckman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 14101 Parkway Commons, Oklahoma City, OK 73134 Phone: 405-749-6277 | |
Robert K Gelczer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St., Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
Vikas Vij, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
William G Phillips, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2224 Nw 50th St, Suite 276w, Oklahoma City, OK 73112 Phone: 405-858-2350 | |
Ronald Ray Magee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5224 E I 240 Service Rd Ste 303, Oklahoma City, OK 73135 Phone: 405-608-3800 Fax: 405-628-6477 |